The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis

PURPOSE: Elective pelvic lymph node radiotherapy (PLNRT) in prostate cancer is often omitted from definitive (n = 267) and post prostatectomy (n = 160) radiotherapy (RT) due to concerns regarding toxicity and efficacy. Data comparing patient-reported outcome measures (PROMs) with or without PLNRT is...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Garrett L., Jhavar, Sameer G., Ha, Chul S, Hammonds, Kendall P., Swanson, Gregory P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256976/
https://www.ncbi.nlm.nih.gov/pubmed/35813937
http://dx.doi.org/10.1016/j.ctro.2022.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256976/
https://www.ncbi.nlm.nih.gov/pubmed/35813937
http://dx.doi.org/10.1016/j.ctro.2022.06.008

Ejemplares similares